Angiomyofibroblastoma of the vulva.
10.5468/ogs.2013.56.5.349
- Author:
Jung Won SEO
1
;
Kyoung A LEE
;
Na Ra YOON
;
Jeong Won LEE
;
Byoung Gie KIM
;
Duk Soo BAE
Author Information
1. Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. garden.lee@samsung.com
- Publication Type:Case Report
- Keywords:
Angiomyofibroblastoma;
Vulva
- MeSH:
Adult;
Blood Vessels;
Cinnarizine;
Desmin;
Estrogens;
Female;
Humans;
Keratins;
Myxoma;
Receptors, Progesterone;
Recurrence;
Vimentin;
Vulva
- From:Obstetrics & Gynecology Science
2013;56(5):349-351
- CountryRepublic of Korea
- Language:English
-
Abstract:
Angiomyofibroblastoma (AMFB) is an uncommon benign mesenchymal tumor. AMFB occurs almost in the vulvo-vaginal area of women. The gross features of AMFB are well-circumscribed so it clinically is often thought as Bartholin gland cyst or aggressive angiomyxoma. Usually, most tumors grow slowly, and patients do not feel pain. It also has low tendency for local recurrence. The histologic findings of the tumors are abundant thin-walled blood vessels with hypocellular and hypercellular areas. Almost all tumor cells have immunoreactivity for both desmin and vimentin. It also has estrogen and/or progesterone receptors, but staining for cytokeratin is negative. Here is a case of AMFB of the vulva occurring in a 40-year-old woman, involving the right labia majora. The patient described that her vulva mass grew in about few months. The maximum dimension of the tumor was measured as 2 cm, and we resected the tumor one month after as her second visit.
